Novel Prognostic Biomarkers in Gastric Cancer: CGB5, MKNK2, and PAPPA2
IntroductionGastric cancer is one of the most common malignant tumors of the digestive tract. However, there are no adequate prognostic markers available for this disease. The present study used bioinformatics to identify prognostic markers for gastric cancer that would guide the clinical diagnosis...
Main Authors: | Min Qin, Zhihai Liang, Heping Qin, Yifang Huo, Qing Wu, Huiying Yang, Guodu Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.683582/full |
Similar Items
-
The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis
by: Zhijun Hong, et al.
Published: (2024-01-01) -
Prognostic marker identification based on weighted gene co-expression network analysis and associated in vitro confirmation in gastric cancer
by: Haonan Guo, et al.
Published: (2021-01-01) -
Identification Of key prognostic genes in ovarian cancer using WGCNA and LASSO analysis
by: Zhong Yu, et al.
Published: (2022-12-01) -
Immune-Related Genes to Construct a Novel Prognostic Model of Breast Cancer: A Chemosensitivity-Based Study
by: Zhi-Min Deng, et al.
Published: (2021-10-01) -
A Risk Model of Eight Immune-Related Genes Predicting Prognostic Response to Immune Therapies for Gastric Cancer
by: Miao Yu, et al.
Published: (2022-04-01)